Glaucoma Diagnostics Market Expected to Rise Steadily throughout 2019 2029

Glaucoma is one of the major eye disorder which affects the optic nerve carrying information from eye to brain. According to report from WHO Glaucoma is the second leading cause for total blindness. Traditionally topical medications and laser surgery especially trabeculotomy are principal methods to treatment glaucoma. The high risk due to complications and high cost associated with the treatment procedures have created the grounds for new safe and effective methods. Prior moving forward an accurate diagnosis is essential for the effective treatment. The Glaucoma Diagnostics offers leverage in determining the condition of intraocular pressure, optic nerve, and drainage angle. The Glaucoma Diagnostics include the Corneal Pachymeters, Optical Coherence Tomography (OCT) Imaging Systems. Which facilitate the particular outline of the glaucoma formation in the eye. The Glaucoma Diagnostics offers advantage over traditional diagnostic procedures as it decreases the probability of miss-diagnosis, it also offers preoperative benefits.

Request a report sample to gain valuable insights >>> https://www.factmr.com/connectus/sample?flag=S&rep_id=4003

Glaucoma Diagnostics Market: Drivers and Restraints

The primary driving factor for Glaucoma Diagnostics market is raising geriatric population which is majorly affected by glaucoma. Novel technique and shorter duration of procedure is luring high numbers of end users, directly propelling the growth for the Glaucoma Diagnostics market. The raising awareness for minimal invasive surgeries in eye disorders and increased utilization of the Glaucoma Diagnostics over the study period is anticipated to propel the growth for the Glaucoma Diagnostics market. Latest technological advancement and improved accuracy profile of the Glaucoma Diagnostics is aiding the growth of the market. Increasing adoption of Optical Coherence Tomography by Ophthalmologist and lab technicians, which is anticipated to propel the growth for the Glaucoma Diagnostics market. However, rigid reimbursement scenario for Glaucoma Diagnostics is anticipated to restrain the growth of the Glaucoma Diagnostics market

Glaucoma Diagnostics Market: Segmentation

The global Glaucoma Diagnostics market can be segmented on the basis of product type, indication type, end user, and geography.

Based on the product type, the global Glaucoma Diagnostics market is segmented as:

  • Optical Coherence Tomography Imaging Systems
  • Retinal Tomography and Retinal Angiography Systems
  • Corneal Pachymeters
  • Visual Field Testing Devices
  • Tonometers,
  • Others

Based on indication Type, the global Glaucoma Diagnostics market is further segmented as:

  • Open angle glaucoma
  • Low tension glaucoma
  • Pigmentary glaucoma
  • Closed angle glaucoma
  • Others

Based on the end user, the global Glaucoma Diagnostics market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Ophthalmology Diagnostic Centers
  • Research Institutes

Request Methodology & Get a Glimpse of Our Expertize >>> https://www.factmr.com/connectus/sample?flag=EB&rep_id=4003

Glaucoma Diagnostics Market: Overview.

The global Glaucoma Diagnostics market is anticipated to show significant growth as Optical Coherence Tomography (OCT) Imaging Systems, Corneal Pachymeters, Tonometers offers greater advantage over tradition procedures for diagnosis of glaucoma. The recent advancement in the intraocular imaging technology is anticipated to offer lucrative market opportunity in the Glaucoma Diagnostics market. The recent advancement in the technological aspect of the Glaucoma Diagnostics such Disc stereo photography is expected to promote competition in the Glaucoma Diagnostics market. In the forthcoming years, the global Glaucoma Diagnostics market is anticipated to witness the entry of new market players which would increase market competition in the Glaucoma Diagnostics market. Introduction of high end cooular coherence tomography in diagnosis of open angle glaucoma is anticipated to fuel the competition in the Glaucoma Diagnostics market

Glaucoma Diagnostics Market: Regional Outlook

Geographically, the global Glaucoma Diagnostics market is segmented into regions viz. North America, Europe, East Asia, Latin America, South Asia, Middle East and Africa (MEA) and the Oceania. North America is estimated to be the dominant market in the global Glaucoma Diagnostics market owing to large number of patients opting for eye surgeries for glaucoma. Moreover, government aid in the funding for research and development in the Glaucoma Diagnostics and technology is anticipated to lead the market growth for the Glaucoma Diagnostics. The Glaucoma Diagnostics market in the East Asia and South Asia is expected to grow significantly due to the increasing healthcare spending and recent rise in healthcare standards in China and India. Europe is expected to hold a second largest share in the global Glaucoma Diagnostics market throughout the forecast period owning to the increased number of minimal invasive surgical procedure directly fueling the demand for Glaucoma Diagnostics.

Glaucoma Diagnostics Market: Key Players

The global market for Glaucoma Diagnostics is fragmented with few number of market players. Examples of some of the key players operating in the global Glaucoma Diagnostics market are NIDEK CO., LTD, Topcon Corporation, Heidelberg Engineering GmbH, Carl Zeiss Meditec AG, Optovue Incorporated, Leica Microsystems, and Haag-Streit Group.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Share Your Requirements & Get Customized Reports >>> https://www.factmr.com/connectus/sample?flag=RC&rep_id=4003

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Matched content

Editor’s pick

Express Press Release Distribution